Physician Wealth Advisors’s Northeast Bank NBN Stock Holding History

Physician Wealth Advisors’s Portfolio NBN Stock Details NBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$531	Hold	4	–	–	﹤0.01%	2096
2026 Q1	$450	Hold	4	–	–	﹤0.01%	1963
2025 Q4	$416	Buy	+4	New	+$373	﹤0.01%	1952

Other funds holding NBN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Ampfield Management New York $100M AUM 19.77% 1-Year Est. Return

Physician Wealth Advisors's NBN Position: Q2 2026 in Review

Physician Wealth Advisors held its Northeast Bank (NBN) position steady in Q2 2026 at 4 shares worth $531. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Physician Wealth Advisors first reported a position in NBN in Q4 2025 and has held it in 3 quarters since. 178 funds tracked by Wall St. Rank hold NBN as of Q2 2026.

Physician Wealth Advisors held 4 shares of Northeast Bank worth $531 as of Q2 2026.
Physician Wealth Advisors left its Northeast Bank share count unchanged in Q2 2026.
Northeast Bank made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2096 holding.
Physician Wealth Advisors first reported a position in Northeast Bank in Q4 2025 and has held it in 3 quarters since.
178 funds tracked by Wall St. Rank held Northeast Bank as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.